Complications of permanent cardiac pacing and implantable cardioverter-defibrillators;Il rischio iatrogeno connesso all'impianto di pacemaker e defibrillatori

Giornale Italiano di Cardiologia

Volumn 10, Issue 6, 2009, Pages 395-406

  Bongiorni, Maria Grazia ^a,b   Di Cori, Andrea ^a   Soldati, Ezio ^a   Zucchelli, Giulio ^a   Segreti, Luca ^a   Solarino, Gianluca ^a   De Lucia, Raffaele ^a   Sergi, Domenico ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiac resynchronization therapy; Iatrogenic complications; Implantable cardioverter defibrillators; Pacemakers

Indexed keywords

CARDIOLOGIST; CENTRAL VENOUS CATHETER; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC SHOCK; EMBOLISM; EROSION; EXPERIENCE; HEART ARRHYTHMIA; HEART PACING; HUMAN; IMPLANTATION; INFECTION; PAIN; PERFORATION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PROSTHESIS FAILURE; REVIEW; RISK FACTOR; SKILL; AIR EMBOLISM; ARTIFICIAL HEART PACEMAKER; BLOOD VESSEL; ELECTROCARDIOGRAPHY; ELECTRONICS; EQUIPMENT; EQUIPMENT DESIGN; HEART INJURY; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HEMATOTHORAX; INJURY; INTRAOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RISK ASSESSMENT; VEIN THROMBOSIS;

ARRHYTHMIAS, CARDIAC; BLOOD VESSELS; CARDIAC SURGICAL PROCEDURES; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EMBOLISM, AIR; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HEART INJURIES; HEMATOMA; HEMOTHORAX; HUMANS; INTRAOPERATIVE PERIOD; MINIATURIZATION; PACEMAKER, ARTIFICIAL; PNEUMOTHORAX; POSTOPERATIVE PERIOD; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR; VENOUS THROMBOSIS; VENTRICULAR FIBRILLATION;

EID: 67649233775     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Brinker J, Midei MG. Techniques of pacemaker implantation and removal. In: Ellenbogen KA, Wood MA, eds. Cardiac pacing and ICDs. 4th edition. Oxford, MA: Blackwell Publishing, 2005: 231-263
2. Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol 1998; 2: 175-179
3. Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol 2000; 85: 774-776 (Pubitemid 30133406)
4. Weigand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol 2003; 26: 1961-1969
5. Hildick-Smith DJ, Lowe MD, Newell SA, et al. Ventricular pacemaker upgrade: experience, complications and recommendations. Heart 1998; 79: 383-387 (Pubitemid 28197756)
6. Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart 1998; 80: 240-244 (Pubitemid 28440341)
7. Oude Ophuis AJ, van Doorn DJ, van Ommen VA, den Dulk K, Wellens HJ. Internal balloon compression: a method to achieve hemostasis when removing an inadvertently placed pacemaker lead from the subclavian artery. Pacing Clin Electrophysiol 1998; 21: 2673-2676 (Pubitemid 29031414)
8. Hilfiker PR, Razavi MK, Kee ST, Sze DY, Semba CP, Dake MD. Stent-graft therapy for subclavian artery aneurysms and fistulas: single-center mid-term results. J Vasc Interv Radiol 2000; 11: 578-584 (Pubitemid 30365586)
9. Rotem CE, Greig JH, Walters MB. Air embolism to the pulmonary artery during insertion of transvenous endocardial pacemaker. J Thorac Cardiovasc Surg 1967; 53: 562-565
10. Glikson M, von Feldt LK, Suman VJ, Hayes DL. Clinical surveillance of an active fixation, bipolar, polyurethane insulated pacing lead. Part I: The atrial lead. Pacing Clin Electrophysiol 1994; 17: 1399-1404 (Pubitemid 24243386)
11. Barold SS, Center S. Electrocardiographic diagnosis of perforation of the heart by pacing catheter electrode. Am J Cardiol 1969; 24: 274-278
12. Sharifi M, Sorkin R, Lakier JB. Left heart pacing and cardioembolic stroke. Pacing Clin Electrophysiol 1994; 17: 1691-1696 (Pubitemid 24299981)
13. Van Gelder BM, Bracke FA, Oto A, et al. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature. Pacing Clin Electrophysiol 2000; 23: 877-883 (Pubitemid 30331749)
14. Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy. Chest 2004; 126: 1177-1186 (Pubitemid 39391248)
15. Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol 1998; 21: 1192-1195 (Pubitemid 28270050)
16. Zuber M, Huber P, Fricker U, Buser P, Jager K. Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol 1998; 21: 2621-2630 (Pubitemid 29031408)
17. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002; 25: 1605-1611 (Pubitemid 35398922)
18. Bayliss CE, Beanlands DS, Baird RJ. The pacemaker-Twiddler's syndrome: a new complication of implantable transvenous pacemakers. Can Med Assoc J 1968; 99: 371-373
19. Pinski SL, Trohman RG. Interference in implanted cardiac devices. Part I. Pacing Clin Electrophysiol 2002; 25: 1367-1381 Completa ed esaustiva rassegna circa le potenziali interferenze tra sorgenti esogene e dispositivi elettrici impiantabili.
20. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 2002; 25: 1496-1509 (Pubitemid 35222808)
21. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 2006; 295: 1901-6. Accurate analisi retrospettiva dei report relativi al malfunzionamento di pacemaker e defibrillatori impiantabili comunicata dalle ditte produttrici alla Food and Drug Administration nel periodo 1990-2002.
22. Amin MS, Matchar DB, Wood MA, Ellenbogen KA. Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. JAMA 2006; 296: 412-20. (Pubitemid 44127525)
23. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998; 97: 1796-1801 Metanalisi dei principali trial relativi all'utilizzo della profilassi antibiotica in corso di impianto di pacemaker. (Pubitemid 28213623)
24. Wilkoff BL, Cook JR, Epstein AE, et al, for the DAVID Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123
25. Steinberg JS, Fischer A, Wang P, et al, for the MADIT II Investigators. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol 2005; 16: 359-365
26. Byrd CL. Management of device related infections. In: Ellenbogen KA, Wilkoff BL, Kay GN, Lau CP, eds. Clinical cardiac pacing, defibrillation and resynchronization therapy. Philadelphia, PA: Saunders-Elsevier, 2007: 855-930.
27. Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000; 23 (4 Pt 1): 544-551 (Pubitemid 30226930)
28. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104: 1029-1033 (Pubitemid 32803880)
29. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-608 (Pubitemid 30778448)
30. Tascini C, Bongiorni MG, Gemignani G, et al. Management of cardiac device infections: a retrospective survey of a non-surgical approach combining antibiotic therapy with transvenous removal. J Chemother 2006; 18: 157-163 (Pubitemid 43774290)
31. Bongiorni MG, Di Cori A, Soldati E, et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 2008; 25: 632-638 (Pubitemid 351861993)
32. Bongiorni MG, Soldati E, Zucchelli G, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J 2008; 29: 2886-2893 Analisi retrospettiva di una delle più importanti esperienze internazionali circa l'utilizzo della tecnica meccanica di rimozione transvenosa di elettrocateteri da stimolazione e defibrillazione.
33. Bongiorni MG, Giannola G, Arena G, et al. Pacing and implantable cardioverter-defibrillator transvenous lead extraction. Ital Heart J 2005; 6: 261-266
34. Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685-1691 (Pubitemid 351626414)
35. Klug D, Balde M, Pavin D, et al, for the PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349-1355
36. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237
37. Chen L, Hay JW. Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure. Cardiovasc Drugs Ther 2004; 18: 161-170 (Pubitemid 38987363)
38. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30: 675-700.
39. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol 2007; 18: 326-328 (Pubitemid 46255956)
40. Klein RC, Raitt MH, Wilkoff BL, et al, for the AVID Investigators. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003; 14: 940-948 (Pubitemid 37115157)
41. Daubert JP, Zareba W, Cannom DS, et al, for the MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365
42. Leon AR, Abraham WT, Curtis AB, et al, for the MIRACLE Study Program. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2000 patients from a multicenter study program. J Am Coll Cardiol 2005; 46: 2348-2356
43. Stevenson WG, Chiatman BR, Ellenbogen KA, et al, for the Subcommittee on Electrocardiography and Arrhythmias of the American Heart Association Council on Clinical Cardiology; Heart Rhythm Society. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 2004; 110: 3866-3869
44. Bhatta L, Luck JC, Wolbrette DL, Naccarelli GV. Complications of biventricular pacing. Curr Opin Cardiol 2004; 19: 31-35 (Pubitemid 39107137)
45. Di Cori A, Bongiorni MG, Arena G, et al. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005; 12: 231-235 (Pubitemid 41201699)
46. Bristow MR, Saxon LA, Boehmer J, et al, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150